Chitose Internasional Tbk. vs Merck Tbk. — how do they compare? Chitose Internasional Tbk. trades at Rp166 (market cap 166B, 77.9K 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Merck Tbk. is far larger — about 10.1× Chitose Internasional Tbk.'s market cap, and Chitose Internasional Tbk. is more actively traded (77.9K versus 33.3K). Which is the better fit depends on your goals.
| CINT | MERK | |
|---|---|---|
Market Cap | 166B | 1.68T |
Volume | 77.9K | 33.3K |
Lot | 779 | 333 |
Turnover | 12.99M | 126.46M |
Average Price | 166.74 | 3,797.72 |
Value | 12.99M | 126.46M |
Indicative Equilibrium Price | 168 | 3,800 |
Indicative Equilibrium Volume | 16 | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Read more on CINT →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →